METHADOSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methadose, and what generic alternatives are available?
Methadose is a drug marketed by Specgx Llc and is included in three NDAs.
The generic ingredient in METHADOSE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methadose
A generic version of METHADOSE was approved as methadone hydrochloride by ROXANE on March 8th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHADOSE?
- What are the global sales for METHADOSE?
- What is Average Wholesale Price for METHADOSE?
Summary for METHADOSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 30 |
Clinical Trials: | 7 |
Patent Applications: | 3,137 |
Drug Prices: | Drug price information for METHADOSE |
What excipients (inactive ingredients) are in METHADOSE? | METHADOSE excipients list |
DailyMed Link: | METHADOSE at DailyMed |
Recent Clinical Trials for METHADOSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bruyere Research Institute | Phase 3 |
Ottawa Hospital Research Institute | Phase 3 |
The Ottawa Hospital | Phase 3 |
Pharmacology for METHADOSE
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
US Patents and Regulatory Information for METHADOSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specgx Llc | METHADOSE | methadone hydrochloride | CONCENTRATE;ORAL | 017116-002 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Specgx Llc | METHADOSE | methadone hydrochloride | TABLET;ORAL | 040050-002 | Apr 15, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | METHADOSE | methadone hydrochloride | TABLET, FOR SUSPENSION;ORAL | 074184-001 | Apr 29, 1993 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Specgx Llc | METHADOSE | methadone hydrochloride | TABLET;ORAL | 040050-001 | Apr 15, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |